WO2007136227A1 - Non-spherical three-dimensional micro-scaffold for cell culture and delivery prepared using rapid prototyping system - Google Patents
Non-spherical three-dimensional micro-scaffold for cell culture and delivery prepared using rapid prototyping system Download PDFInfo
- Publication number
- WO2007136227A1 WO2007136227A1 PCT/KR2007/002494 KR2007002494W WO2007136227A1 WO 2007136227 A1 WO2007136227 A1 WO 2007136227A1 KR 2007002494 W KR2007002494 W KR 2007002494W WO 2007136227 A1 WO2007136227 A1 WO 2007136227A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- scaffold
- micro
- cell culture
- twisted
- strip
- Prior art date
Links
- 238000004113 cell culture Methods 0.000 title claims abstract description 43
- -1 polytrimethylene carbonate Polymers 0.000 claims abstract description 28
- 229920000249 biocompatible polymer Polymers 0.000 claims abstract description 21
- 229920000954 Polyglycolide Polymers 0.000 claims abstract description 11
- 229920000747 poly(lactic acid) Polymers 0.000 claims abstract description 11
- 239000002253 acid Substances 0.000 claims abstract description 8
- 229920001432 poly(L-lactide) Polymers 0.000 claims abstract description 8
- 229920001308 poly(aminoacid) Polymers 0.000 claims abstract description 8
- 229920006324 polyoxymethylene Polymers 0.000 claims abstract description 8
- 229920001661 Chitosan Polymers 0.000 claims abstract description 6
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 claims abstract description 6
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 4
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229920002101 Chitin Polymers 0.000 claims abstract description 4
- 102000008186 Collagen Human genes 0.000 claims abstract description 4
- 108010035532 Collagen Proteins 0.000 claims abstract description 4
- 108010010803 Gelatin Proteins 0.000 claims abstract description 4
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229930182556 Polyacetal Natural products 0.000 claims abstract description 4
- 239000004952 Polyamide Substances 0.000 claims abstract description 4
- 229920002732 Polyanhydride Polymers 0.000 claims abstract description 4
- 229920001273 Polyhydroxy acid Polymers 0.000 claims abstract description 4
- 229920001710 Polyorthoester Polymers 0.000 claims abstract description 4
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 4
- 229940072056 alginate Drugs 0.000 claims abstract description 4
- 229920000615 alginic acid Polymers 0.000 claims abstract description 4
- 235000010443 alginic acid Nutrition 0.000 claims abstract description 4
- 229920003232 aliphatic polyester Polymers 0.000 claims abstract description 4
- 229920001436 collagen Polymers 0.000 claims abstract description 4
- 150000002148 esters Chemical class 0.000 claims abstract description 4
- 229920000159 gelatin Polymers 0.000 claims abstract description 4
- 239000008273 gelatin Substances 0.000 claims abstract description 4
- 235000019322 gelatine Nutrition 0.000 claims abstract description 4
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 4
- 150000004676 glycans Chemical class 0.000 claims abstract description 4
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 4
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 4
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 claims abstract description 4
- 229920002627 poly(phosphazenes) Polymers 0.000 claims abstract description 4
- 229920002647 polyamide Polymers 0.000 claims abstract description 4
- 229920000768 polyamine Polymers 0.000 claims abstract description 4
- 229920000515 polycarbonate Polymers 0.000 claims abstract description 4
- 239000004417 polycarbonate Substances 0.000 claims abstract description 4
- 229920002721 polycyanoacrylate Polymers 0.000 claims abstract description 4
- 239000000622 polydioxanone Substances 0.000 claims abstract description 4
- 229920006149 polyester-amide block copolymer Polymers 0.000 claims abstract description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 4
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 4
- 239000005017 polysaccharide Substances 0.000 claims abstract description 4
- 229920000166 polytrimethylene carbonate Polymers 0.000 claims abstract description 4
- 229920002635 polyurethane Polymers 0.000 claims abstract description 4
- 239000004814 polyurethane Substances 0.000 claims abstract description 4
- 229920002554 vinyl polymer Polymers 0.000 claims abstract description 4
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 claims abstract description 4
- 125000003277 amino group Chemical group 0.000 claims abstract description 3
- PJRSUKFWFKUDTH-JWDJOUOUSA-N (2s)-6-amino-2-[[2-[[(2s)-2-[[(2s,3s)-2-[[(2s)-2-[[2-[[(2s)-2-[[(2s)-6-amino-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[(2-aminoacetyl)amino]-4-methylsulfanylbutanoyl]amino]propanoyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]propanoyl]amino]acetyl]amino]propanoyl Chemical compound CSCC[C@H](NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O PJRSUKFWFKUDTH-JWDJOUOUSA-N 0.000 claims abstract 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract 2
- 108010021753 peptide-Gly-Leu-amide Proteins 0.000 claims abstract 2
- 229920001610 polycaprolactone Polymers 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 5
- 239000002131 composite material Substances 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 3
- 238000012546 transfer Methods 0.000 claims description 2
- 238000002347 injection Methods 0.000 abstract description 20
- 239000007924 injection Substances 0.000 abstract description 20
- 238000001727 in vivo Methods 0.000 abstract description 7
- 210000004504 adult stem cell Anatomy 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 54
- 239000001963 growth medium Substances 0.000 description 15
- 230000035755 proliferation Effects 0.000 description 14
- 238000002054 transplantation Methods 0.000 description 10
- 230000004663 cell proliferation Effects 0.000 description 7
- 238000009792 diffusion process Methods 0.000 description 7
- 239000004633 polyglycolic acid Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 230000021164 cell adhesion Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 229950008885 polyglycolic acid Drugs 0.000 description 5
- 239000004626 polylactic acid Substances 0.000 description 5
- 229940124597 therapeutic agent Drugs 0.000 description 5
- 239000000969 carrier Substances 0.000 description 4
- 230000004069 differentiation Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 230000003068 static effect Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000009423 ventilation Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 239000011325 microbead Substances 0.000 description 3
- 230000005012 migration Effects 0.000 description 3
- 238000013508 migration Methods 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 206010064571 Gene mutation Diseases 0.000 description 2
- 238000012832 cell culture technique Methods 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000000411 inducer Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 150000001412 amines Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229920001897 terpolymer Polymers 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
- C12N5/0075—General culture methods using substrates using microcarriers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y70/00—Materials specially adapted for additive manufacturing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
- C12M25/14—Scaffolds; Matrices
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
- C12M25/16—Particles; Beads; Granular material; Encapsulation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y80/00—Products made by additive manufacturing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
- C12N2533/40—Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin
Definitions
- the present invention relates to a three-dimensional micro-scaffold for cell culture.
- the micro-scaffold is used to provide an environment where cells can grow.
- the present inventors successfully constructed a micro-scaffold made of a bio-compatible polymer material, such as PLLA, PLGA or chitosan, and used the micro-scaffold in cell culture and in vivo transplantation (Korean Patent Registration No. 10-0539371).
- the above-described prior micro-scaffold was designed such that it can perform cell culture and in vivo injection/transplantation, and it is characterized in that it is a spherical micro-bead having a size of 10-lOOD.
- the reason why cell culture efficiency is reduced as described above is because the spherical shape is not suitable in the diffusion of chemical substances, the size of the scaffolds is too small for the space between the scaffolds to perform diffusion, and also the space between the scaffolds becomes narrow as the number of growing cells increases. Moreover, because the spherical internal space does not provide a surface for cell adhesion, the spherical shape is inefficient compared to a non-spherical three-dimensional structure in terms of a total area for cell adhesion. To improve such shortcomings, the present inventors attempted to construct a scaffold having fine pores therein.
- this scaffold is not a completely porous structure, culture medium is not difficult to diffuse through the scaffold, and the rate of differentiation in the desired direction can greatly vary depending on the shape of the scaffold even in the same chemical environment (culture medium, etc).
- culture medium is not difficult to diffuse through the scaffold, and the rate of differentiation in the desired direction can greatly vary depending on the shape of the scaffold even in the same chemical environment (culture medium, etc).
- cell adhesion and proliferation rate are increased and the migration of cells to the surrounding scaffolds can easily occur.
- materials having low hydrophilicity cells very rapidly proliferate to the saturation density in the phase in which cells form colonies, but the migration of cells to the surrounding scaffolds is slow.
- the present inventors have recognized that the shape and material of micro-scaffolds must be greatly varied depending to the kind and intended use of cells to differentiate.
- the need for transplantation by injection is very important, but the injection of the cell therapeutic agents is possible only by a thin injection needle having a diameter of less than 200D, because of the characteristics of human vascular vessels.
- the cell therapeutic agent does not freely pass through the above-described thin injection needle, the transplantation thereof by injection becomes impossible, and a damaged b lood vessel cannot be repaired, resulting in risk.
- the cell therapeutic agents should necessarily be prototypes having a diameter smaller than that of the above injection needle, and thus there is still a need to develop a micro-scaffold, which serves as an effective support for cell culture and, at the same time, can be injected in vivo.
- Another object of the present invention is to provide suitable micro-prototypes, which can perform all the proliferation and differentiation of stem cells for biotechnology and the role of carriers for injection.
- a micro-scaffold for cell culture and delivery prepared by a rapid prototyping (RP) system using a piezo-, bubble jet- or thermal jet-type spray nozzle
- the micro- scaffold comprising a biocompatible polymer selected from the group consisting of PLA, PLLA, PGA, PGLA, PCL, chitosan, polylactides, polyglycolides, epsilon- caprolactone, polyhydroxyvaleric acid, polyhydroxybutyric acid, other polyhydroxy acids, polytrimethylene carbonate, polyamines, vinyl polymers, polyacrylic acids and their derivatives containing ester, polyethylene glycols, polydioxanones, polycarbonates, polyacetals, polyorthoesters, polyamino acids, polyphosphoesters, polyesteramides, polyfumerates, polyanhydrides, polycyanoacrylates, polyoxamers, polyurethanes, polyphospha
- the three-dimensional structure is a circular tube, a polygonal tube, or a three-dimensional structure, which further comprises a plurality of holes or tubular branches on the side of these tubes.
- the micro-scaffold according to the present invention may have a composite structure in which a drug transporter is connected to the three-dimensional structure.
- a micro- scaffold for cell culture or delivery which is prepared by a rapid prototyping system using a biocompatible polymer, the micro-scaffold having a Moebius strip-shaped, twisted band or twisted tubular structure, which has a single twist, such that one side of the strip is connected to the other side in an upside-down manner without in- termittence, and thus there is no distinction between the inside and outside surfaces.
- the micro-scaffold having this structure is the simplest structure with no distinction between the inside and outside surfaces and most efficiently employs the properties of cells, which grow only on the same surface in cell culture. This principle will be more clearly understood with reference to FIG. 13.
- the present invention provides a micro-scaffold for cell culture or delivery prepared by a rapid prototyping system using a biocompatible polymer, the micro-scaffold having a modified Moebius strip-shaped, twisted band or twisted tubular structure, which has two twists or more, such that one side of the strip is connected to the other side in an upside-down manner without intermittence, and thus there is no distinction between the inside and outside surfaces.
- This structure is a modified structure, which includes the characteristic of the simplest Moebius strip and has additional twists. In this structure, one side of the strip is connected to the other side, but the strip is twisted two times or more.
- the sides of the strips cross with each other to form an 8-like shape or a ribbon shape.
- This structure requires a prototyping operation, which is more complicated compared to the case of the Moebius strip having a single twist, and it can be entangled.
- it can be modified such that the sides thereof cross each other, and thus the distance between the scaffold surfaces spaced apart from each other is reduced, thus increasing the probability that cells migrate to other scaffolds. Accordingly, it is a scaffold shape which can provide a more advantageous effect in cell culture.
- the present invention provides a micro-scaffold for cell culture or delivery prepared by a rapid prototyping system using a biocompatible polymer, the micro-scaffold having a Klein bottle- or Klein jar-like twisted bottle or twisted tubular structure, in which the inlet and outlet of the structure join each other through a surface of the outer wall of the structure, and thus are one and the same.
- the advantages of this structure are that it can stably protect cells, ensures a sufficient cell growth space, has no distinction between the inside and outside surfaces, and thus is most efficient in terms of the properties of cells which grow along the same surface. Also, another advantage is that the diffusion of culture medium on this structure uniformly occurs without distinction between the inside and outside surfaces.
- micro-scaffold of the present invention may be a porous structure having at least one hole.
- the micro-scaffold according to the present invention may be a composite structure in which a drug transporter is connected to the micro-scaffold.
- the micro-scaffold according to the present invention can be prepared using a known rapid prototyping (RP) technique. As already known, it is currently possible to form even a nano-scale three-dimensional micro-scaffold using the three-dimensional rapid prototyping technology.
- RP rapid prototyping
- the RP system is preferably a spray nozzle type such as a piezo, bubble jet or thermal jet in order to produce a large amount of a non-spherical three-dimensional shape having pores or holes therein using a biocompatible polymer as a raw material.
- PLA poly lactic acid
- PLLA poly L-lactic acid
- PGA poly glycolic acid
- PGLA polyglycolic/lactic acid
- PCL poly e- carprolactone
- chitosan and the like can be used alone or in combination.
- other examples include polylactides, polyglycolides, epsilon-caprolactone, polyhy- droxyvaleric acid, polyhydroxybutyric acid, other polyhydroxy acids, polytrimethylene carbonate, polyamines, vinyl polymers, polyacrylic acids and their derivatives including esters, polyethylene glycols, polydioxanones, polycarbonates, polyacetals, polyorthoesters, polyamino acids, polyphosphoesters, polyesteramides, polyfumerates, polyanhydrides, polycyanoacrylates, polyoxamers, polyurethanes, polyphosphazenes, aliphatic polyesters, poly(amino acid), copoly (ether-ester), polyakylene oxalate, polyamides, poly(io acid
- biocompatible polymers which can be used in the present invention as described above, including chitosan, PLA (poly lactic acid), PLLA (poly L-lactic acid), PGA (poly glycolic acid), PGLA (polyglycolic/lactic acid), PCL (poly e-carprolactone) and the like are known to be suitable for the human body through numerous clinical tests, and the use of these polymers provides an advantage of reducing the period of a clinical test, which takes about 5-10 years.
- the three-dimensional structure intended in the present invention may be a polyhedral structure having pores or holes for ventilation or a three-dimensional structure having various shapes of ring, band or non-spherical structure with the internal space.
- the micro-scafflod of such structure provides a space for cells to adhere and grow and provides a mechanical and electrical environment suitable for proliferation and differentiation of cell, thereby ensuring the optimal culture environment and efficiency.
- the shape of each scaffold can be made to be different for cells, it is basically formed to have the maximum surface area for attachment, the attachment environment with the maximum efficiency and the ventilation with the maximum efficiency so as to form the space advantageous for diffusion of the culture fluid in the scaffold or between scaffolds.
- the scaffold is shaped to be suitable for characteristics and size of cells.
- Such three-dimensional structures include a circular tube, a polygonal tube, a structure having a plurality of holes or tubular branches on the side of the tube, and a polyhedron whose inner space is exposed to an external environment.
- Such structures are formed in combination with each other, or two or more structures are connected to each other. Also, such structures may be made of a plurality of materials having different decomposition rates.
- a Moebius strip-shaped or Klein bottle-shaped scaffold having at least one twist which is used for cell culture or delivery, can be formed using a biocompatible polymer as a raw material.
- These three-dimensional structures are non-spherical, and thus provide a maximum surface area in which cells can adhere and grow. Also, these structures optimize a mechanical and electrical environment required for the proliferation and differentiation of cells. Moreover, these structures have a completely porous structure, which facilitates the diffusion of culture medium and the transfer of chemical signals, so that the rate of cell migration to the surrounding scaffolds is increased, thus increasing cell culture efficiency.
- micro-scaffold can be used in three-dimensional cell culture to perform either a cell culture process comprising periodically repeating a static status and the moving status of the micro-scaffold, or a cell culture process comprising slowly increasing the amount of the micro-scaffold, in which the cell culture processes are simultaneously or individually performed.
- a cell culture process comprising periodically repeating a static status and the moving status of the micro-scaffold
- a cell culture process comprising slowly increasing the amount of the micro-scaffold, in which the cell culture processes are simultaneously or individually performed.
- the non-spherical micro-scaffold provides high culture efficiency compared to a simple spherical scaffold.
- the above micro-scaffold consists of a three-dimensional structure having a maximum size of 20-10OD and has a ventilation space formed therein.
- the collection, cultured cell and the micro-scaffold and in vivo transplantation of cells can be performed in a single syringe without needing to move the cells.
- cells are collected using a syringe, the piston of which can be opened and closed, and then the cells are centrifuged so as to be suitable for proliferation and are washed.
- the piston of the syringe is opened, and culture medium and a powder-type scaffold (micro-scaffold) are placed into the syringe, and the cells are suspended in the culture medium.
- the stem cells are adhered to the micro- scaffold, and the cell attached micro-scaffold is precipitated in the culture medium.
- the cells are cultured, and after a given time of culture, culture medium and the micro-scaffold are added to the syringe through the syringe opening. Then, the micro-scaffold is moved to allow the cells to proliferate, and the proliferation is periodically repeated. In this way, the closed loop cell culture method using the syringe can be applied.
- the cells, which were cultured and proliferated according to the above method have an advantage in that they can be transplanted into the human body without causing damage to blood vessel tissue.
- the present invention provides a micro-scaffold for three-dimensional cell culture, which is prepared by a rapid prototyping system so as to have a ventilation space formed therein.
- the micro-scaffold can perform all the roles of cell proliferation scaffolds, differentiation inducers and scaffolds, and carriers for injection.
- the micro-scaffold structure according to the present invention has a high ability to diffuse culture medium into the internal space thereof, includes surfaces joined with each other, and thus has high cell adhesion efficiency. Also, it has a size capable of passing through an injection needle and comprises an internal space which allows the volume of the structure to be reduced. Accordingly, it can be transplanted using an injection needle for transplantation, and thus facilitates the transplantation of target cells by injection. In addition, it is made of a material, which was found to be biocompatible through clinical tests, and thus the clinical test thereof can be reduced.
- FIGS. 1 and 2 are views showing an embodiment of the three-dimensional scaffold of a square tube type
- FIGS. 3 and 4 are views showing an embodiment of the three-dimensional scaffold of a column type
- FIG. 5 is a view showing an embodiment of the three-dimensional scaffold of a honeycomb type
- FIG. 6 is a view showing an embodiment of the three-dimensional scaffold of a flute type
- FIGS. 7 to 10 are views showing an embodiment of the three-dimensional scaffold of a Moebius band type
- FIGs. 11 and 12 are views showing an embodiment of the three-dimensional scaffold of a Klein bottle type.
- FIG. 13 is a view showing the difference in the efficiency of cell culture between the scaffold of the general band type and the scaffold of a Moebius band type. Best Mode for Carrying Out the Invention
- FIG. 1 to FIG. 6 illustrate various shapes of the micro-scaffold prepared using the RP system according to the present invention.
- FIG. 1 is a square tube type with a hollow center
- FIG. 2 is a square tube with openings, which is prepared using a biocompatible polymer by the RP system and has a maximum size of 20 to 100D.
- FTG. 3 and FIG. 4 are each a cylindrical shape and FIG. 4 has openings to improve air permeability on the side wall. They are prepared using a biocompatible polymer by the RP system and formed to have a maximum size of 20 to 10OD.
- FIG. 5 and 6 are a honeycomb shape and a flute shape, respectively, in which spaces formed therein ensure air permeability and provide spaces in which cells can grow. Also, the structures are similar to those of the brain, liver or nerve cells, whereby they can be effectively applied in the culture and transplantation of such cells. Each of the structures is prepared using a biocompatible polymer by the RP system and formed to have a maximum size of 20 to 10OD.
- FlG. 7 to FTG. 10 are tubular or band-type Moebius strip structures, in which one side of the strip is connected to other side in an upside-down manner, so that there is no distinction between the inside and outside surfaces.
- the structures have one twist (FlG. 7 and FlG. 8), two twists (FlG. 9) or three twists (FlG. 10).
- the structures are each formed of a biocompatible polymer by a RP system and have a maximum size of 20 to 10OD.
- the structures are classified into a shape having a single twist, a shape having an even number of twists (more than two twists) and a shape having an odd number of twists (more than three twists).
- the Moebius strip structure is the simplest prototype with no distinction between the inside and outside surfaces and most efficiently employ the properties of cells which rapidly grow only one surface.
- This strip structure shows elasticity upon transplantation by injection without being entangled and can ensure the largest space with a minimum amount of scaffolds.
- this structure has high cell culture and proliferation efficiencies and can be transplanted in vivo by a syringe in a cultured state.
- FlG. 11 and FlG. 12 show scaffolds for cell culture or delivery prepared using a biocompatible polymer by the RP system, the scaffolds having the structure of the Klein bottle (or the Klein jar). These scaffolds have the shape of a twisted bottle or tube, in which the inlet and outlet of the structure meet each other through a surface of the outer wall thereof, so that the inlet and outlet are one and the same.
- Each of the scaffolds is prepared from a biocompatible polymer using the RP system and has a maximum size of 20-100 D.
- the structure of the scaffold according to the present invention has a space for cell protection and growth and, at the same time has no distinction between the inside and outside surfaces.
- it is the most efficient scaffold for cells which proliferate along a surface.
- the diffusion of culture medium on the scaffold is uniform and the probability that the scaffolds are entangled with each other is low.
- the inventive scaffold is suitable for cells, which show relatively fast growth during the proliferation thereof and differentiate for a long period of time.
- the above-described three-dimensional structures can be prepared to have a plurality of holes therein.
- the plurality of such structures can be formed in combination with each other, or may be made of a plurality of materials including a drug transporter.
- Such structures are 3-dimentional structure, which can consider the culture and proliferation of specific cells or the physical and chemical properties of specific cells, and they will contribute to an increase in cell culture and proliferation efficiencies.
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Materials Engineering (AREA)
- Cell Biology (AREA)
- Manufacturing & Machinery (AREA)
- Immunology (AREA)
- Sustainable Development (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention provides a three-dimensional non-spherical micro-scaffold for cell culture and delivery. The micro-scaffold is prepared using a biocompatible polymer selected from the group consisting of PLA, PLLA, PGA, PGLA, PCL, chitosan, polylactides, polyglycolides, epsilon-caprolactone, polyhydroxyvaleric acid, polyhydroxybutyric acid, other polyhydroxy acids, polytrimethylene carbonate, polyamines, vinyl polymers, polyacrylic acids and their derivatives containing ester, polyethylene glycols, polydioxanones, polycarbonates, polyacetals, polyorthoesters, polyamino acids, polyphosphoesters, polyesteramides, polyfumerates, polyanhydrides, polycyanoacrylates, polyoxamers, polyurethanes, polyphosphazenes, aliphatic polyesters, poly(amino acid), copoly(ether-ester), polyakylene oxalate, polyamides, poly(iminocarbonate), polyoxaester, polyamidoesters, amine group-containing polyoxaester, polyacetal, polyalkanoate, gelatin, collagen, elastine, polysaccharide, alginate, chitin, hyaluronic acid, and combinations thereof, as a biocompatible polymer for use in the in vitro culture and in vivo injection of adult stem cells, by a RP (rapid prototyping) system with a spry nozzle. The three-dimensional micro-scaffold have a Moebius strip-shaped, twisted band or twisted tubular structure, which has a one or two or more twists, such that one side of the strip is connected to the other side in an upside-down manner without intermittence, and thus there is no distinction between the inside and outside surfaces. Alternatively, the structure has a Klein bottle- or Klein jar-like twisted bottle or twisted tubular structure, in which the inlet and outlet of the structure meet each other through a surface of the outer wall of the structure, so that the inlet and the outlet are one and the same.
Description
Description
NON-SPHERICAL THREE-DIMENSIONAL MICRO-SCAFFOLD
FOR CELL CULTURE AND DELIVERY PREPARED USING
RAPID PROTOTYPING SYSTEM
Technical Field
[1] The present invention relates to a three-dimensional micro-scaffold for cell culture.
Background Art
[2] In the field of biotechnology and related technologies, various culture methods have been used to increase the number of cells. Among them, a three-dimensional cell culture technique that uses powder-type scaffolds (micro-scaffolds, micro-beads or micro-carriers) in culture media is known. In order to further improve this three- dimensional cell culture technique, the present inventors suggested a cell culture method comprising periodically repeating a static status and the moving status of the scaffold, that is, shaking, rolling, stirring, whirling, rocking, mixing, blending, rotation or the like, and a cell culture method comprising slowly increasing the amount of the scaffold, in which the cell culture methods are simultaneously or individually carried out. According to these cell culture methods, when an environment where cell proliferation is accelerated by cell-to-cell signals or interactions is properly used in cell culture and, at the same time, proliferated cells adhere to each other, it is possible to minimize the phenomenon that proliferation inhibitory signals occur while the relative ratio of an area where cells can proliferate is reduced. Also, intercellular separation for increasing cell proliferation efficiency is performed using physical force instead of using a chemical method, which is known to have a possibility of causing gene mutation (see Korean Patent Application No. 2006-0031995).
[3] In the above-described three-dimensional cell culture method, the micro-scaffold is used to provide an environment where cells can grow. The present inventors successfully constructed a micro-scaffold made of a bio-compatible polymer material, such as PLLA, PLGA or chitosan, and used the micro-scaffold in cell culture and in vivo transplantation (Korean Patent Registration No. 10-0539371).
[4] The above-described prior micro-scaffold was designed such that it can perform cell culture and in vivo injection/transplantation, and it is characterized in that it is a spherical micro-bead having a size of 10-lOOD.
[5] In the case of the above-described method in which the static status and the moving status are controlled while the amount of scaffold added is slowly increased (Korean Patent Application No. 2006-0031995), an excellent effect on culture efficiency can be obtained, however, because an increase in the amount of culture medium makes the
penetration of culture medium difficult, the scaffold and cells are precipitated in the static status, which is important in cell culture, and thus cell culture efficiency is reduced in a position spaced more than a few mm apart from the interface with the culture medium. It is believed that the reason why cell culture efficiency is reduced as described above is because the spherical shape is not suitable in the diffusion of chemical substances, the size of the scaffolds is too small for the space between the scaffolds to perform diffusion, and also the space between the scaffolds becomes narrow as the number of growing cells increases. Moreover, because the spherical internal space does not provide a surface for cell adhesion, the spherical shape is inefficient compared to a non-spherical three-dimensional structure in terms of a total area for cell adhesion. To improve such shortcomings, the present inventors attempted to construct a scaffold having fine pores therein. However, because this scaffold is not a completely porous structure, culture medium is not difficult to diffuse through the scaffold, and the rate of differentiation in the desired direction can greatly vary depending on the shape of the scaffold even in the same chemical environment (culture medium, etc). Particularly, in the case of highly hydrophilic materials, cell adhesion and proliferation rate are increased and the migration of cells to the surrounding scaffolds can easily occur. In the case of materials having low hydrophilicity, cells very rapidly proliferate to the saturation density in the phase in which cells form colonies, but the migration of cells to the surrounding scaffolds is slow. Thus, the present inventors have recognized that the shape and material of micro-scaffolds must be greatly varied depending to the kind and intended use of cells to differentiate. [6] Due to the recent development of rapid prototyping (RP) technology, nanoscale prototyping had become possible in rapid prototypes which use inorganic materials as raw materials, but prototyping devices, which use polymers, have been developed and produced for industrial purposes, and so there is little or no recognition of a need to apply the rapid prototyping technology for prototypes having a resolution of less than 1OD. Thus, rapid prototyping of micro-scaffolds (for example, a size of less than 100 D) using biocompatible polymer materials has not been substantially studied. Even in attempts to perform the rapid prototyping of scaffolds, the scaffolds are used merely in cell culture and are intended to be transplanted in vivo together with cultured cells by injection, and the scaffolds mostly have a size much larger than 10OD. Accordingly, such rapid prototypes cannot be used in three-dimensional cell culture as an efficient proliferation method and are not impossible to inject through a thin injection needle. Thus, in order for cells supported and cultured on scaffolds resulting from such rapid prototypes to be used as cell therapeutic agents for injection in clinical applications, it is required to perform additional operations, including separating cells from the scaffolds for cell culture, and if cells are not separated from the scaffolds prior to
injection, the transplantation of the cells is possible only through excision operations which involve a large amount of bleeding.
[7] Moreover, conventional polymers for rapid prototypes are not yet clinically approved or are impossible to clinically approve even in the future, and a time of about 10 years will be required until the polymers will be used in clinical applications.
[8] In order for cell therapeutic agents to be used in practical clinical applications, the need for transplantation by injection is very important, but the injection of the cell therapeutic agents is possible only by a thin injection needle having a diameter of less than 200D, because of the characteristics of human vascular vessels. Thus, if the cell therapeutic agent does not freely pass through the above-described thin injection needle, the transplantation thereof by injection becomes impossible, and a damaged b lood vessel cannot be repaired, resulting in risk. For this reason, the cell therapeutic agents should necessarily be prototypes having a diameter smaller than that of the above injection needle, and thus there is still a need to develop a micro-scaffold, which serves as an effective support for cell culture and, at the same time, can be injected in vivo.
Disclosure of Invention Technical Problem
[9] It is an object of the present invention to provide the most three-dimensional efficient micro-prototypes, which are obtained through an already developed three-dimensional micro-prototyping technology in consideration of various problems, including the diffusion of culture medium, cell adhesion efficiency, passage through injection needles, the final intended use of cells (sites to be treated: liver, heart, brain, etc.), and biocompatibility, in order for the micro-prototypes to perform all the roles of proliferation scaffold, differentiation inducers and scaffolds, and carriers for injection.
[10] Another object of the present invention is to provide suitable micro-prototypes, which can perform all the proliferation and differentiation of stem cells for biotechnology and the role of carriers for injection.
[11] Particularly, it is an object of the present invention to provide a three-dimensional structure with no distinction between the inside and outside surfaces, considering the fact that the formation of cell colonies on the same surface is achieved at a rate faster than migration to the surrounding scaffolds and that cell culture is more advantageously achieved when the inside and outside surfaces are connected with each other. Technical Solution
[12] In order to achieve the above objects, according to the present invention, there is provided a micro-scaffold for cell culture and delivery prepared by a rapid prototyping (RP) system using a piezo-, bubble jet- or thermal jet-type spray nozzle, the micro-
scaffold comprising a biocompatible polymer selected from the group consisting of PLA, PLLA, PGA, PGLA, PCL, chitosan, polylactides, polyglycolides, epsilon- caprolactone, polyhydroxyvaleric acid, polyhydroxybutyric acid, other polyhydroxy acids, polytrimethylene carbonate, polyamines, vinyl polymers, polyacrylic acids and their derivatives containing ester, polyethylene glycols, polydioxanones, polycarbonates, polyacetals, polyorthoesters, polyamino acids, polyphosphoesters, polyesteramides, polyfumerates, polyanhydrides, polycyanoacrylates, polyoxamers, polyurethanes, polyphosphazenes, aliphatic polyesters, poly(amino acid), copoly(ether-ester), polyakylene oxalate, polyamides, poly(iminocarbonate), polyoxaester, polyamidoesters, amine group-containing polyoxaester, polyacetal, polyalkanoate, gelatin, collagen, elastine, polysaccharide, alginate, chitin, hyaluronic acid, and combinations thereof, the micro-scaffold having a three dimensional structure with a maximum diameter of 100 D or less. Preferably, the micro-scaffold has the maximum diameter of 20 to 10OD.
[13] Preferably, the three-dimensional structure is a circular tube, a polygonal tube, or a three-dimensional structure, which further comprises a plurality of holes or tubular branches on the side of these tubes. Also, the micro-scaffold according to the present invention may have a composite structure in which a drug transporter is connected to the three-dimensional structure.
[14] In another aspect according to the present invention, there is provided a micro- scaffold for cell culture or delivery, which is prepared by a rapid prototyping system using a biocompatible polymer, the micro-scaffold having a Moebius strip-shaped, twisted band or twisted tubular structure, which has a single twist, such that one side of the strip is connected to the other side in an upside-down manner without in- termittence, and thus there is no distinction between the inside and outside surfaces. The micro-scaffold having this structure is the simplest structure with no distinction between the inside and outside surfaces and most efficiently employs the properties of cells, which grow only on the same surface in cell culture. This principle will be more clearly understood with reference to FIG. 13.
[15] In another embodiment, the present invention provides a micro-scaffold for cell culture or delivery prepared by a rapid prototyping system using a biocompatible polymer, the micro-scaffold having a modified Moebius strip-shaped, twisted band or twisted tubular structure, which has two twists or more, such that one side of the strip is connected to the other side in an upside-down manner without intermittence, and thus there is no distinction between the inside and outside surfaces. This structure is a modified structure, which includes the characteristic of the simplest Moebius strip and has additional twists. In this structure, one side of the strip is connected to the other side, but the strip is twisted two times or more. Thus, at any one point, the sides of the
strips cross with each other to form an 8-like shape or a ribbon shape. This structure requires a prototyping operation, which is more complicated compared to the case of the Moebius strip having a single twist, and it can be entangled. However, as the number of twists therein increases, it can be modified such that the sides thereof cross each other, and thus the distance between the scaffold surfaces spaced apart from each other is reduced, thus increasing the probability that cells migrate to other scaffolds. Accordingly, it is a scaffold shape which can provide a more advantageous effect in cell culture.
[16] In still another embodiment, the present invention provides a micro-scaffold for cell culture or delivery prepared by a rapid prototyping system using a biocompatible polymer, the micro-scaffold having a Klein bottle- or Klein jar-like twisted bottle or twisted tubular structure, in which the inlet and outlet of the structure join each other through a surface of the outer wall of the structure, and thus are one and the same. The advantages of this structure are that it can stably protect cells, ensures a sufficient cell growth space, has no distinction between the inside and outside surfaces, and thus is most efficient in terms of the properties of cells which grow along the same surface. Also, another advantage is that the diffusion of culture medium on this structure uniformly occurs without distinction between the inside and outside surfaces.
[17] Furthermore, the micro-scaffold of the present invention may be a porous structure having at least one hole.
[18] Also, the micro-scaffold according to the present invention may be a composite structure in which a drug transporter is connected to the micro-scaffold.
[19] The micro-scaffold according to the present invention can be prepared using a known rapid prototyping (RP) technique. As already known, it is currently possible to form even a nano-scale three-dimensional micro-scaffold using the three-dimensional rapid prototyping technology. In the present invention, a rapid prototyping (RP) system having three or more axes and an axial resolution of less than 5 D is used to the above- described micro-scaffold. The RP system is preferably a spray nozzle type such as a piezo, bubble jet or thermal jet in order to produce a large amount of a non-spherical three-dimensional shape having pores or holes therein using a biocompatible polymer as a raw material.
[20] As the biocompatible polymer, PLA (poly lactic acid), PLLA (poly L-lactic acid),
PGA (poly glycolic acid), PGLA (polyglycolic/lactic acid), PCL (poly e- carprolactone), chitosan and the like can be used alone or in combination. Also, other examples include polylactides, polyglycolides, epsilon-caprolactone, polyhy- droxyvaleric acid, polyhydroxybutyric acid, other polyhydroxy acids, polytrimethylene carbonate, polyamines, vinyl polymers, polyacrylic acids and their derivatives including esters, polyethylene glycols, polydioxanones, polycarbonates, polyacetals,
polyorthoesters, polyamino acids, polyphosphoesters, polyesteramides, polyfumerates, polyanhydrides, polycyanoacrylates, polyoxamers, polyurethanes, polyphosphazenes, aliphatic polyesters, poly(amino acid), copoly (ether-ester), polyakylene oxalate, polyamides, poly(iminocarbonate), polyoxaester, polyamidoesters, amine group- containing polyoxaester, polyacetal, polyalkanoate, gelatin, collagen, elastine, polysaccharide, alginate, chitin, hyaluronic acid, and copolymers or terpolymers thereof. The biocompatible polymers which can be used in the present invention as described above, including chitosan, PLA (poly lactic acid), PLLA (poly L-lactic acid), PGA (poly glycolic acid), PGLA (polyglycolic/lactic acid), PCL (poly e-carprolactone) and the like are known to be suitable for the human body through numerous clinical tests, and the use of these polymers provides an advantage of reducing the period of a clinical test, which takes about 5-10 years.
[21] The three-dimensional structure intended in the present invention may be a polyhedral structure having pores or holes for ventilation or a three-dimensional structure having various shapes of ring, band or non-spherical structure with the internal space. The micro-scafflod of such structure provides a space for cells to adhere and grow and provides a mechanical and electrical environment suitable for proliferation and differentiation of cell, thereby ensuring the optimal culture environment and efficiency. Though the shape of each scaffold can be made to be different for cells, it is basically formed to have the maximum surface area for attachment, the attachment environment with the maximum efficiency and the ventilation with the maximum efficiency so as to form the space advantageous for diffusion of the culture fluid in the scaffold or between scaffolds. Also, the scaffold is shaped to be suitable for characteristics and size of cells. Such three-dimensional structures include a circular tube, a polygonal tube, a structure having a plurality of holes or tubular branches on the side of the tube, and a polyhedron whose inner space is exposed to an external environment. Such structures are formed in combination with each other, or two or more structures are connected to each other. Also, such structures may be made of a plurality of materials having different decomposition rates.
[22] Also, when the rapid prototyping system is used, a Moebius strip-shaped or Klein bottle-shaped scaffold having at least one twist, which is used for cell culture or delivery, can be formed using a biocompatible polymer as a raw material.
[23] These three-dimensional structures are non-spherical, and thus provide a maximum surface area in which cells can adhere and grow. Also, these structures optimize a mechanical and electrical environment required for the proliferation and differentiation of cells. Moreover, these structures have a completely porous structure, which facilitates the diffusion of culture medium and the transfer of chemical signals, so that the rate of cell migration to the surrounding scaffolds is increased, thus increasing cell
culture efficiency.
[24] The above-described micro-scaffold (micro-bead) can be used in three-dimensional cell culture to perform either a cell culture process comprising periodically repeating a static status and the moving status of the micro-scaffold, or a cell culture process comprising slowly increasing the amount of the micro-scaffold, in which the cell culture processes are simultaneously or individually performed. Thus, when an environment where cell proliferation is accelerated by cell-to-cell signals or interactions is properly used in cell culture and, at the same time, proliferated cells adhere to each other, it is possible to minimize the phenomenon that proliferation inhibitory signals occur while the relative ratio of an area where cells can proliferate is reduced. Also, intercellular separation for increasing cell proliferation efficiency is performed using physical force instead of using a chemical method, which is known to have a possibility of causing gene mutation. Accordingly, the non-spherical micro-scaffold provides high culture efficiency compared to a simple spherical scaffold.
[25] Also, the above micro-scaffold consists of a three-dimensional structure having a maximum size of 20-10OD and has a ventilation space formed therein. Thus, when the micro-scaffold is used, the collection, cultured cell and the micro-scaffold and in vivo transplantation of cells can be performed in a single syringe without needing to move the cells. Specifically, cells are collected using a syringe, the piston of which can be opened and closed, and then the cells are centrifuged so as to be suitable for proliferation and are washed. The piston of the syringe is opened, and culture medium and a powder-type scaffold (micro-scaffold) are placed into the syringe, and the cells are suspended in the culture medium. In this state, the stem cells are adhered to the micro- scaffold, and the cell attached micro-scaffold is precipitated in the culture medium. In the state in which the piston is opened, the cells are cultured, and after a given time of culture, culture medium and the micro-scaffold are added to the syringe through the syringe opening. Then, the micro-scaffold is moved to allow the cells to proliferate, and the proliferation is periodically repeated. In this way, the closed loop cell culture method using the syringe can be applied. The cells, which were cultured and proliferated according to the above method, have an advantage in that they can be transplanted into the human body without causing damage to blood vessel tissue. Advantageous Effects
[26] The present invention provides a micro-scaffold for three-dimensional cell culture, which is prepared by a rapid prototyping system so as to have a ventilation space formed therein. Thus, the micro-scaffold can perform all the roles of cell proliferation scaffolds, differentiation inducers and scaffolds, and carriers for injection.
[27] The micro-scaffold structure according to the present invention has a high ability to
diffuse culture medium into the internal space thereof, includes surfaces joined with each other, and thus has high cell adhesion efficiency. Also, it has a size capable of passing through an injection needle and comprises an internal space which allows the volume of the structure to be reduced. Accordingly, it can be transplanted using an injection needle for transplantation, and thus facilitates the transplantation of target cells by injection. In addition, it is made of a material, which was found to be biocompatible through clinical tests, and thus the clinical test thereof can be reduced. Brief Description of the Drawings
[28] Further objects and advantages of the invention can be more fully understood from the following detailed description taken in conjunction with the accompanying drawings, in which:
[29] FIGS. 1 and 2 are views showing an embodiment of the three-dimensional scaffold of a square tube type;
[30] FIGS. 3 and 4 are views showing an embodiment of the three-dimensional scaffold of a column type;
[31] FIG. 5 is a view showing an embodiment of the three-dimensional scaffold of a honeycomb type;
[32] FIG. 6 is a view showing an embodiment of the three-dimensional scaffold of a flute type;
[33] FIGS. 7 to 10 are views showing an embodiment of the three-dimensional scaffold of a Moebius band type;
[34] FIGs. 11 and 12 are views showing an embodiment of the three-dimensional scaffold of a Klein bottle type; and
[35] FIG. 13 is a view showing the difference in the efficiency of cell culture between the scaffold of the general band type and the scaffold of a Moebius band type. Best Mode for Carrying Out the Invention
[36] Now, the three-dimensional shape of the micro-scaffold is described in detail with reference to the accompanying drawings.
[37] FIG. 1 to FIG. 6 illustrate various shapes of the micro-scaffold prepared using the RP system according to the present invention.
[38] FIG. 1 is a square tube type with a hollow center, and FIG. 2 is a square tube with openings, which is prepared using a biocompatible polymer by the RP system and has a maximum size of 20 to 100D.
[39] FTG. 3 and FIG. 4 are each a cylindrical shape and FIG. 4 has openings to improve air permeability on the side wall. They are prepared using a biocompatible polymer by the RP system and formed to have a maximum size of 20 to 10OD.
[40] FIG. 5 and 6 are a honeycomb shape and a flute shape, respectively, in which spaces
formed therein ensure air permeability and provide spaces in which cells can grow. Also, the structures are similar to those of the brain, liver or nerve cells, whereby they can be effectively applied in the culture and transplantation of such cells. Each of the structures is prepared using a biocompatible polymer by the RP system and formed to have a maximum size of 20 to 10OD.
[41] FlG. 7 to FTG. 10 are tubular or band-type Moebius strip structures, in which one side of the strip is connected to other side in an upside-down manner, so that there is no distinction between the inside and outside surfaces. The structures have one twist (FlG. 7 and FlG. 8), two twists (FlG. 9) or three twists (FlG. 10). Also, the structures are each formed of a biocompatible polymer by a RP system and have a maximum size of 20 to 10OD. The structures are classified into a shape having a single twist, a shape having an even number of twists (more than two twists) and a shape having an odd number of twists (more than three twists).
[42] The Moebius strip structure is the simplest prototype with no distinction between the inside and outside surfaces and most efficiently employ the properties of cells which rapidly grow only one surface. This strip structure shows elasticity upon transplantation by injection without being entangled and can ensure the largest space with a minimum amount of scaffolds. Thus, this structure has high cell culture and proliferation efficiencies and can be transplanted in vivo by a syringe in a cultured state.
[43] FlG. 11 and FlG. 12 show scaffolds for cell culture or delivery prepared using a biocompatible polymer by the RP system, the scaffolds having the structure of the Klein bottle (or the Klein jar). These scaffolds have the shape of a twisted bottle or tube, in which the inlet and outlet of the structure meet each other through a surface of the outer wall thereof, so that the inlet and outlet are one and the same. Each of the scaffolds is prepared from a biocompatible polymer using the RP system and has a maximum size of 20-100 D.
[44] During cell proliferation, cells cannot cross the boundary between the surfaces of a scaffold and can grow only a surface of the same phase. As shown in FlG. 13, in the case of conventional band structures, cells will proliferate on only one surface of the inside and outside surfaces as a scaffold, both the surfaces cannot be used for the proliferation of cells. However, in the inventive scaffold having a shape with no distinction between the inside and outside surfaces, cells can proliferate on both the surfaces, and thus the inventive scaffold is clearly a more efficient scaffold.
[45] Accordingly, as shown in FlG. 13, the structure of the scaffold according to the present invention has a space for cell protection and growth and, at the same time has no distinction between the inside and outside surfaces. Thus, it is the most efficient scaffold for cells which proliferate along a surface. Also, the diffusion of culture medium on the scaffold is uniform and the probability that the scaffolds are entangled
with each other is low. Thus, the inventive scaffold is suitable for cells, which show relatively fast growth during the proliferation thereof and differentiate for a long period of time.
[46] The above-described three-dimensional structures, including the Moebius strip structure or the Klein bottle structure, can be prepared to have a plurality of holes therein. The plurality of such structures can be formed in combination with each other, or may be made of a plurality of materials including a drug transporter. Such structures are 3-dimentional structure, which can consider the culture and proliferation of specific cells or the physical and chemical properties of specific cells, and they will contribute to an increase in cell culture and proliferation efficiencies.
Claims
[1] A three-dimensional non-spherical micro-scaffold for cell culture and delivery prepared using a RP (rapid prototyping) system with a piezo-, bubble jet- or thermal jet-type spray nozzle, the micro-scaffold being made of a biocompatible polymer selected from the group consisting of PLA, PLLA, PGA, PGLA, PCL, chitosan, polylactides, polyglycolides, epsilon-caprolactone, polyhydroxyvaleric acid, polyhydroxybutyric acid, other polyhydroxy acids, polytrimethylene carbonate, polyamines, vinyl polymers, polyacrylic acids and their derivatives containing ester, polyethylene glycols, polydioxanones, polycarbonates, polyacetals, polyorthoesters, polyamino acids, polyphosphoesters, polyesteramides, polyfumerates, polyanhydrides, polycyanoacrylates, polyoxamers, polyurethanes, polyphosphazenes, aliphatic polyesters, poly(amino acid), copoly(ether-ester), polyakylene oxalate, polyamides, poly(iminocarbonate), polyoxaester, polyamidoesters, amine group-containing polyoxaester, polyacetal, polyalkanoate, gelatin, collagen, elastine, polysaccharide, alginate, chitin, hyaluronic acid, and combinations thereof, the micro-scaffold having a maximum diameter of 100 D or less.
[2] The micro-scaffold according to claim 1, wherein the three-dimensional structure is a circular tube, a polygonal tube, or a three-dimensional structure comprising a plurality of holes or tubular branches provided on the side of the tubes.
[3] The micro-scaffold according to claim 1, wherein the three-dimensional structure is a composite structure in which a drug transporter is connected to the th ree- dimensional structure.
[4] A micro-scaffold for cell culture or delivery prepared using a biocompatible polymer by a rapid prototyping system, the micro-scaffold having a Moebius strip-shaped, twisted band or twisted tubular structure, which has a single twist, such that one side of the strip is connected with the other side in an upside-down manner without intermittence, and thus there is no distinction between the inside and outside surfaces of the strip.
[5] A micro-scaffold for cell culture or delivery prepared using a biocompatible polymer by a rapid prototyping system, the micro-scaffold having a Moebius s trip-shaped twisted band or twisted tubular structure, which has two or more twists, such that one side of the strip is connected to the other side in an upside- down manner without intermittence, and thus there is no distinction between the inside and outside surfaces of the strip.
[6] A micro-scaffold for cell culture or transfer prepared using a biocompatible polymer by a rapid prototyping system, the micro-scaffold having a Klein bottle-
or Klein jar-like twisted bottle or twisted tubular structure, in which the inlet and outlet of the structure meet each other through a surface of the outer wall of the structure, so that the inlet and the outlet are one and the same.
[7] The micro-scaffold according to any one of claims 4 to 6, which is a porous structure having one or more holes.
[8] The micro-scaffold according to any one of claims 4 to 6, which is a composite structure in which a drug transporter is connected to the micro-scaffold.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2006-0046172 | 2006-05-23 | ||
KR20060046172 | 2006-05-23 | ||
KR10-2006-0079725 | 2006-08-23 | ||
KR1020060079725A KR100799320B1 (en) | 2006-05-23 | 2006-08-23 | Three-dimensional rp-patterns of micro-scaffold for cell culture |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007136227A1 true WO2007136227A1 (en) | 2007-11-29 |
Family
ID=38723517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2007/002494 WO2007136227A1 (en) | 2006-05-23 | 2007-05-23 | Non-spherical three-dimensional micro-scaffold for cell culture and delivery prepared using rapid prototyping system |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007136227A1 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101219240B (en) * | 2008-01-18 | 2010-11-10 | 清华大学 | Production method for living body tissue with channel |
WO2011017930A1 (en) * | 2009-08-11 | 2011-02-17 | 南方医科大学珠江医院 | Macroporous microcarrier specific to liver cell, preparation mathod and use thereof |
US8080418B2 (en) | 2007-03-09 | 2011-12-20 | Corning Incorporated | Method of making a three dimensional cell culture matrix |
CN102886070A (en) * | 2012-09-14 | 2013-01-23 | 上海大学 | Sodium alginate and chitosan skin tissue engineering scaffold material and preparation method thereof |
WO2013103306A1 (en) * | 2012-01-05 | 2013-07-11 | A4Tec - Association For The Advancement Of Tissue Engineering And Cell Based Technologies &Therapies | Bioreactor composed of watertight chamber and internal matrix for the generation of cellularized medical implants |
CN108853585A (en) * | 2018-08-01 | 2018-11-23 | 北京大学 | Application of the porous micro rack in regeneration and restoration |
EP3278765A4 (en) * | 2015-03-31 | 2018-12-05 | Revotek Co., Ltd | Rotary device for biological printing, and method of use thereof |
US11065601B2 (en) | 2015-12-18 | 2021-07-20 | University Of Canterbury | Separation medium |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5888930A (en) * | 1989-03-27 | 1999-03-30 | Bend Research, Inc. | Asymmetric microporous beads for controlled release |
US20020155559A1 (en) * | 2001-01-17 | 2002-10-24 | Laurencin Cato T. | Biocompatible, biodegradable polymer-based, lighter than or light as water scaffolds for tissue engineering and methods for preparation and use thereof |
JP2003024966A (en) * | 2001-07-13 | 2003-01-28 | Dainippon Plastics Co Ltd | Microorganism carrier for treating waste water and method for treating waste water using the same |
JP2004105099A (en) * | 2002-09-19 | 2004-04-08 | Inoac Corp | Microorganism carrier |
-
2007
- 2007-05-23 WO PCT/KR2007/002494 patent/WO2007136227A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5888930A (en) * | 1989-03-27 | 1999-03-30 | Bend Research, Inc. | Asymmetric microporous beads for controlled release |
US20020155559A1 (en) * | 2001-01-17 | 2002-10-24 | Laurencin Cato T. | Biocompatible, biodegradable polymer-based, lighter than or light as water scaffolds for tissue engineering and methods for preparation and use thereof |
JP2003024966A (en) * | 2001-07-13 | 2003-01-28 | Dainippon Plastics Co Ltd | Microorganism carrier for treating waste water and method for treating waste water using the same |
JP2004105099A (en) * | 2002-09-19 | 2004-04-08 | Inoac Corp | Microorganism carrier |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8080418B2 (en) | 2007-03-09 | 2011-12-20 | Corning Incorporated | Method of making a three dimensional cell culture matrix |
CN101219240B (en) * | 2008-01-18 | 2010-11-10 | 清华大学 | Production method for living body tissue with channel |
WO2011017930A1 (en) * | 2009-08-11 | 2011-02-17 | 南方医科大学珠江医院 | Macroporous microcarrier specific to liver cell, preparation mathod and use thereof |
WO2013103306A1 (en) * | 2012-01-05 | 2013-07-11 | A4Tec - Association For The Advancement Of Tissue Engineering And Cell Based Technologies &Therapies | Bioreactor composed of watertight chamber and internal matrix for the generation of cellularized medical implants |
CN102886070A (en) * | 2012-09-14 | 2013-01-23 | 上海大学 | Sodium alginate and chitosan skin tissue engineering scaffold material and preparation method thereof |
EP3278765A4 (en) * | 2015-03-31 | 2018-12-05 | Revotek Co., Ltd | Rotary device for biological printing, and method of use thereof |
EP3689297A1 (en) * | 2015-03-31 | 2020-08-05 | Revotek Co., Ltd | Rotary device for bio-printing and method for using the same |
US11149240B2 (en) | 2015-03-31 | 2021-10-19 | Revotek Co., Ltd | Rotary device for bio-printing and method for using the same |
US11065601B2 (en) | 2015-12-18 | 2021-07-20 | University Of Canterbury | Separation medium |
CN108853585A (en) * | 2018-08-01 | 2018-11-23 | 北京大学 | Application of the porous micro rack in regeneration and restoration |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007136227A1 (en) | Non-spherical three-dimensional micro-scaffold for cell culture and delivery prepared using rapid prototyping system | |
Perez et al. | Core–shell designed scaffolds for drug delivery and tissue engineering | |
Kumar Giri et al. | Alginate based hydrogel as a potential biopolymeric carrier for drug delivery and cell delivery systems: present status and applications | |
JP5931293B2 (en) | Devices and methods for cell culture | |
US20180346873A1 (en) | Artificial micro-gland | |
US9242024B2 (en) | Three-dimensional nanofiber scaffold for tissue repair and preparation method thereof | |
US8198086B2 (en) | Method for production of three-dimensional structure of cells | |
Choi et al. | Biodegradable porous beads and their potential applications in regenerative medicine | |
Correia et al. | Cell encapsulation systems toward modular tissue regeneration: from immunoisolation to multifunctional devices | |
JP6622818B2 (en) | Fine room microstructure and manufacturing method thereof | |
Altobelli et al. | Micro-and nanocarriers by electrofludodynamic technologies for cell and molecular therapies | |
JP6628416B2 (en) | Cell culture method | |
CN103656758B (en) | Tissue engineering bracket imitating intima-media structure and function of natural blood vessels and preparation method thereof | |
AU2012237375A1 (en) | Method for encapsulated therapeutic products and uses thereof | |
Porta et al. | Biomaterials and supercritical fluid technologies: which perspectives to fabricate artificial extracellular matrix? | |
KR100799320B1 (en) | Three-dimensional rp-patterns of micro-scaffold for cell culture | |
Datta et al. | Nanotechnology–the new frontier of medicine | |
Desai et al. | Direct-writing of biomedia for drug delivery and tissue regeneration | |
CN107427606B (en) | Cell culture support | |
Li et al. | Fabrication of polymeric microspheres for biomedical applications | |
Krishnan et al. | The integration of nanotechnology and biology for cell engineering: promises and challenges | |
WO2020261653A1 (en) | Porous body, method for producing porous body, method for transplanting porous body, and cell support | |
EP3089738B1 (en) | Microspheres for delivery of therapeutic agents | |
KR102198478B1 (en) | Microstructure using water-resistant thin-film and method for manufacturing thereof | |
CN115595265A (en) | Cell culture unit, cell culture device and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07746642 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112 (1) EPC (EPOFORM 1205A DATED 24.02.2009) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07746642 Country of ref document: EP Kind code of ref document: A1 |